You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TGFβ receptor II (TGFβRII or TGFβ Trap)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)

Active, not recruiting
  • Rectal Adenocarcinoma
  • Portland, Oregon
    Providence Cancer Center
Mar 22, 2022

NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

Terminated
  • Non-Small Cell Lung Cancer
  • Heidelberg, Victoria, Australia
    Austin Health
Jan 13, 2023

Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

Not yet recruiting
  • Ovarian Cancer
  • Carboplatin AUC 5 and paclitaxel
  • Bintrafusp alfa (M7824)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jul 12, 2022

Transitional Cell Carcinoma of Bladder Trial in Milan (PF03446962)

Completed
  • Transitional Cell Carcinoma of Bladder
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

Not yet recruiting
  • Adenocarcinoma Esophagus
  • +3 more
  • (no location specified)
Sep 13, 2023

Radiotherapy Side Effect, Taking Captopril Trial in Wuhan (Captopril 12.5 Mg)

Recruiting
  • Radiotherapy Side Effect
  • Taking Captopril
  • Captopril 12.5 Mg
  • Wuhan, Hubei, China
    Jin Peng
Jan 29, 2022

Myeloproliferative Tumor Trial in New York (Vactosertib)

Recruiting
  • Myeloproliferative Neoplasm
  • New York, New York
    Weill Medical College of Cornell University
Dec 20, 2021

Pancreatic Cancer Trial in Herlev (drug, radiation, biological)

Not yet recruiting
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Feb 8, 2023

Solid Tumor Trial in Minneapolis (HCW9218)

Recruiting
  • Solid Tumor
  • Minneapolis, Minnesota
    Masonic Cancer Center - University of Minnesota
Apr 12, 2022

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (NIS793, Nab-paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Fayetteville, Arkansas
  • +122 more
Jan 27, 2023

Tumor, Esophagus, Malignant Esophagus Tumor, Tumor, Esophageal Trial in Amsterdam (Bintrafusp alfa)

Recruiting
  • Neoplasm, Esophagus
  • +2 more
  • Bintrafusp alfa
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Jan 15, 2021

Prostate Cancer Trial in Philadelphia (CART-PSMA-TGFßRDN cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Prostate Cancer
  • CART-PSMA-TGFβRDN cells
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 17, 2022

Osteogenesis Imperfecta Trial in Worldwide (SAR439459, Placebo)

Recruiting
  • Osteogenesis Imperfecta
  • New Haven, Connecticut
  • +9 more
Jan 10, 2023

Lung Cancer, Cancer, Immunotherapy Trial in Guangzhou (CAR-T cells targeting PSCA, MUC1, TGFß, HER2, Mesothelin, Lewis-Y, GPC3,

Recruiting
  • Lung Cancer
  • +3 more
  • CAR-T cells targeting PSCA, MUC1, TGFβ, HER2, Mesothelin, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2, or B7-H3
  • Guangzhou, Guangdong, China
  • +1 more
Nov 26, 2021

Stem Cell Factor,Potential Biological Marker of Skin Involvement

Recruiting
  • Systemic Sclerosis
  • ELISA
  • Videocapillaroscopy
  • Brussels, Belgium
    CHU Brugmann
Jul 29, 2022

Idiopathic Pulmonary Fibrosis Trial in San Francisco, Boston, New York (EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone,

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • EGCG + Nintedanib
  • +2 more
  • San Francisco, California
    UCSF Parnassus
Apr 25, 2022

Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Boston (AGEN1423,

Not yet recruiting
  • Advanced Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 18, 2022

Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Beijing Hospital
Feb 3, 2023

Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Prolonged-Release Pirfenidone
  • Guadalajara, Jalisco, Mexico
  • +1 more
Sep 13, 2022

Hepatocellular Carcinoma, Immunotherapy, CAR Trial in Guangzhou (GPC3 and/or TGFß targeting CAR-T cells)

Recruiting
  • Hepatocellular Carcinoma
  • +5 more
  • GPC3 and/or TGFβ targeting CAR-T cells
  • Guangzhou, Guangdong, China
  • +1 more
Nov 28, 2020

Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)

Active, not recruiting
  • Carcinosarcoma, Ovarian
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center, University of Oklahoma Health Sciences
Sep 27, 2021

Klotho _ LRP-6 _ Gastric Adenocarcinoma

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Prognostic study
  • (no location specified)
Jan 29, 2023

Advanced Solid Tumor, Advanced Breast Cancer, Advanced Gastric Cancer Trial in Boston, Dallas, Fairfax (IMM2902)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)

Recruiting
  • Pediatric Sarcoma, Refractory
  • Pediatric Sarcoma, Relapsed
  • GEM/DOX + TGFBi expanded NK cells
  • Tampa, Florida
  • +1 more
Jan 3, 2023

Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

Completed
  • Cardiac Failure
    • Wetzikon, Switzerland
      GZO Regional Health Center
    Jul 13, 2021